Location out of bounds
Back to Test Catalog

Fibrinolytic Disorder Panel

Order Code: 4860

Also Known as

F13A1, F13B, FGA, FGB, FGG, PLAU, SERPINA1, SERPINE1, SERPINF2

Test Information

This genetic panel is optimized for the detection of germline variants in 9 genes known to cause delayed bleeding due to hyperfibrinolysis. This panel evaluates eight of the nine genes in this panel (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, and SERPINF2( by next-generation sequencing. PLAU is evaluated by ACGH Deletion/Duplication Analysis in order to detect the heterozygous 78-kb tandem duplication responsible for the Quebec Platelet Disorder.

Sample Requirements

Amniotic Fluid, Buccal Swabs, Cultured Amniocytes, CVS, DNA, EDTA Bone Marrow, EDTA Whole Blood

Shipping Information

Room Temperature

Requested Volume

2-5 mL EDTA Whole Blood or Bone Marrow (lavender top), 3-4 Buccal Swabs, 1 ug DNA at 50 ng/uL, 7-15 mL Amniotic fluid, 5-10 mg CVS, 2-T25 flasks cultured amniocytes or CVS (2x10^6 minimum)

Minimum/Pediatric Volume

Fetal: Call Laboratory; Parental/Patient: 2 mL

CPT Codes

81479

Method

Capture hybridization and Next Generation Sequencing (miSeq) with supplementary Sanger for quality and coverage; aCGH for PLAU gene

Turnaround Time

21 days

ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more